-
未分類
Veneno Technologies raised 200M Yen ($2M) Seed Funding Round
Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to […] -
未分類
We were selected as a Top 10 BioTech Startups In APAC – 2021 COMPANY OF THE YEAR by Life Sciences Review.
We are pleased to announce that we have been selected as COMPANY OF THE YEAR in the Top 10 BioTech Startups In APAC – 2021 […] -
未分類
Concluded an agreement with NAGASE & CO., LTD. on agency and capital alliance in the DRP drug discovery business
Veneno Technologies Co. Ltd. and NAGASE & CO., LTD. announced that both companies have entered into a distributorship and capital alliance agreement for DRP functional […] -
お知らせ
Conclusion of a Memorandum of Understanding for Joint Research with Curreio, Inc.
We are pleased to announce that we have signed a Memorandum of Understanding (MOU) for joint research with Curreio, Inc., a company with outstanding analytical […]